Atlas Trials

Diabetic Gastroparesis Efficacy/Safety Study of TZP-102

Clinical trial NCT01664637 · TERMINATED

Trial details

NCT number
NCT01664637
Sponsor
Tranzyme, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Gastroparesis
Start date
2012-08-01
Primary completion
2013-01-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.